MENU
BOVNF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Bioinvent International AB (BOVNF) Ownership - Who owns Bioinvent International AB?
BioInvent International AB is a clinical-stage biotech company... Show more
Profile
Industry
N/A
Address
Ideongatan 1
Phone
+46 462868550
Employees
89
Web
https://www.bioinvent.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
241.3M
P/E Ratio
N/A
Total Cash
742.21M
Projected Growth
N/A
Total Debt
15.19M
Revenue
60.8M
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash/Share
11.28
Total Debt/Equity
N/A
Revenue/Share
0.10 USD as % of share price
Fundamentals
BOVNF
Capitalization
241M
P/E Ratio
N/A
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash
742M
Total Cash/Share
11.28
Total Debt
15.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.10%
Revenue
60.8M
ROE
N/A
Book Value
770M
P/B Ratio
2.66
Cash Flow
N/A
Earnings
-7.12
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
9.41
Current Revenue Per Employee
186949.16
Dividends Per Share - Security
N/A
EBITDA
-450.09M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-42.72
Shares Held By Institutions
128M
Shares Outstanding - Current
65.8M
Total Liabilities
93.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-30.030
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Ideongatan 1
Phone
+46 462868550
Employees
89
Web
https://www.bioinvent.com